AMRA Medical Appoints Allison Robbins as Chief Financial Officer

By a News Reporter-Staff News Editor at Defense & Aerospace Week -- AMRA Medical announces the addition of Allison Robbins, CFA to its leadership team. Robbins will serve as Chief Financial Officer on a part-time basis located in the U.S. as the Company looks to expand its commercial partnership reach and fundraising efforts.

Ms. Robbins brings extensive experience from both sides of the investment discussion. During her time at several healthcare-focused investment funds, including Genzyme Ventures, Tullis Health Investors, and Paramount Capital, she completed eight venture capital investments in transformative medical technologies resulting in six IPOs and two M&A transactions and several products on the market or in late-stage clinical development. She has also worked on behalf of numerous operating companies to craft strategy, develop long-range financial forecasts, negotiate transactions, and advance fundraising efforts. Ms. Robbins has also served in foundational operating roles with a U.S. direct-pay primary care practice and a health tech SaaS start-up.

In addition to her role at AMRA Medical, Robbins has been and will continue to provide financial and strategy consulting services to venture capital funds, accelerators, and startups via Green Shoots Consulting, LLC, with a focus on the biotech, device, and digital health industries. Her recent work with large pharmaceutical companies centers on the commercial and research applications of real-world data (RWD) and modern analytics in the medical field.

Ms. Robbins received her MBA with Honors from The Wharton School in Health Care Management and Finance, and her BA, Summa Cum Laude, in Biochemistry and Economics from Dartmouth College. She is a CFA® charterholder.

(Our reports deliver fact-based news of research and discoveries from around the world.)